Cabaletta Bio Inc. Company Profile
NASDAQ: CABAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.97-0.05 (-2.48%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.01 +2.03%
Cabaletta Bio at a glance
Cabaletta Bio Inc. (NASDAQ: CABA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2019. At a market capitalization of $342.5 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001759138, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Cabaletta Bio Inc.
- Ticker
- NASDAQ: CABA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- United States
- IPO year
- 2019
- Market cap
- $342.48M
- SEC CIK
- 0001759138
Companies similar to Cabaletta Bio
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| ARTVArtiva Biotherapeutics Inc. | 7.00 | -3.71% | $342.23M | vs CABA |
| AGENAgenus Inc. | 7.57 | +1.07% | $341.88M | vs CABA |
| OCGNOcugen Inc. | 1.00 | -3.85% | $339.11M | vs CABA |
| CCCCC4 Therapeutics Inc. | 2.82 | -2.08% | $346.93M | vs CABA |
| SCTXScribe Therapeutics Inc. | 17.57 | +7.59% | $332.63M | vs CABA |
| FENCFennec Pharmaceuticals Inc. | 10.36 | +0.10% | $363.30M | vs CABA |
| KYTXKyverna Therapeutics Inc. | 6.17 | +0.16% | $381.57M | vs CABA |
| SRZNSurrozen Inc. | 25.15 | -4.65% | $295.54M | vs CABA |